NEs can bind to circulating tumor cells or inflammatory endothelial cells through ligand receptor interactions, such as CD44 and L-selectin, LFA-1 and ICAM-1, and β 1 integrin and VCAM-1 [137]. The gene discussed is VCAM1; the disease is neoplasm.